Berkeley, CA, United States of America

Carl A Elliger

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Secretary of. Active years: 1976.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Carl A Elliger

Introduction

Carl A Elliger is a notable inventor based in Berkeley, CA (US). He has made significant contributions to the field of chemistry, particularly in the separation of important compounds. His work has implications for various applications in pharmaceuticals and biochemistry.

Latest Patents

Elliger holds a patent for a process that separates DOPA from tyrosine. The patent describes a method where a mixture of tyrosine and 3,4-dihydroxyphenylalanine (DOPA) is applied to a polymer of p-vinylbenzene boronic acid. The process involves serially eluting the tyrosine and DOPA, showcasing Elliger's innovative approach to compound separation.

Career Highlights

Throughout his career, Elliger has been associated with the United States of America as Represented by the Secretary of. His work has been recognized for its scientific merit and practical applications. He has contributed to advancing the understanding of biochemical processes through his inventions.

Collaborations

Elliger has worked alongside notable colleagues such as Bock G Chan and William L Stanley. Their collaborative efforts have furthered research in their respective fields and have led to advancements in the technologies they developed.

Conclusion

Carl A Elliger's contributions to the field of chemistry, particularly through his patent for separating DOPA from tyrosine, highlight his innovative spirit and dedication to scientific advancement. His work continues to influence the industry and inspire future research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…